Please ensure Javascript is enabled for purposes of website accessibility

Novavax gets $4M for COVID-19 vaccine, teams with Emergent (access required)

A Gaithersburg drug company has received $4 million in funding from a nongovernmental organization to develop a COVID-19 vaccine and is teaming with another Gaithersburg drug company for development and manufacturing.

To purchase a reprint of this article, contact [email protected].